Index Entries

Abdelilah Majdoubi, Christina Michalski, Sarah E. O’Connell, Sarah Dada, Sandeep Narpala, Jean Gelinas, Disha Mehta, Claire Cheung, Dirk F.H. Winkler, Manjula Basappa, Aaron C. Liu, Matthias Görges, Vilte E. Barakauskas, Mike Irvine, Jennifer Mehalko, Dominic Esposito, Inna Sekirov, Agatha N. Jassem, David M. Goldfarb, Steven Pelech, Daniel C. Douek, Adrian B. McDermott, and Pascal M. Lavoie
March 15, 2021
JCI Insight
BC Children’s Hospital Research Institute and University of British Columbia (Canada)

Introduction: … While much attention has focused on defining immune reactivity in individuals after infection, other data indicate that many individuals show preexisting SARS-CoV-2 cross-reactive T and B cells without prior exposure to the virus…

Discussion: … The main finding in this study is that, at a population level, the vast majority of adults show anti-body reactivity against SARS-CoV-2 antigens… [I]t is extremely unlikely that this antibody reactivity results from a direct exposure to SARS-CoV-2. Moreover, findings of similar antibody reactivity in prepandemic adult sera and from sera obtained from infants younger than 1 year of age confirms that we are detecting genuine cross-reactivity rather than reactivity to SARS-CoV-2 from asymptomatic COVID-19 cases…

In conclusion, this study reveals common preexisting, broadly reactive SARS-CoV-2 antibodies in uninfected adults.”

document
COVID-19,natural immunity